Shumei Xu

617 total citations
29 papers, 455 citations indexed

About

Shumei Xu is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Shumei Xu has authored 29 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Public Health, Environmental and Occupational Health and 6 papers in Physiology. Recurrent topics in Shumei Xu's work include Acute Myeloid Leukemia Research (3 papers), Alzheimer's disease research and treatments (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Shumei Xu is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Alzheimer's disease research and treatments (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). Shumei Xu collaborates with scholars based in China. Shumei Xu's co-authors include Qingfeng Liu, Xinguo Jiang, Qizhi Zhang, Xiayan Shao, Chi Zhang, Xiaoyao Zheng, Wan Xu, Weiying Liu, Laixiang Lin and Mingwei Jin and has published in prestigious journals such as PLoS ONE, Applied Microbiology and Biotechnology and Pharmaceutical Research.

In The Last Decade

Shumei Xu

27 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shumei Xu China 10 169 104 90 81 58 29 455
Cristina Gomes de Macedo Brazil 14 127 0.8× 151 1.5× 28 0.3× 97 1.2× 18 0.3× 26 553
Mi‐Jin Jang South Korea 14 219 1.3× 30 0.3× 26 0.3× 78 1.0× 25 0.4× 29 699
Peter Ward United States 13 177 1.0× 75 0.7× 20 0.2× 104 1.3× 24 0.4× 25 662
Amparo Buenestado France 9 164 1.0× 109 1.0× 25 0.3× 140 1.7× 23 0.4× 15 577
Robert Wronski Austria 12 138 0.8× 91 0.9× 31 0.3× 12 0.1× 53 0.9× 23 453
Gordon Brandt United States 9 164 1.0× 38 0.4× 30 0.3× 321 4.0× 41 0.7× 12 663
Janet Rice United States 9 199 1.2× 13 0.1× 45 0.5× 47 0.6× 24 0.4× 9 675
Ze Li China 9 81 0.5× 106 1.0× 65 0.7× 15 0.2× 18 0.3× 23 407
Erika Stefàno Italy 10 72 0.4× 113 1.1× 26 0.3× 15 0.2× 19 0.3× 24 404
Aya Tanabe Japan 12 190 1.1× 110 1.1× 14 0.2× 13 0.2× 40 0.7× 23 545

Countries citing papers authored by Shumei Xu

Since Specialization
Citations

This map shows the geographic impact of Shumei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumei Xu more than expected).

Fields of papers citing papers by Shumei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shumei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumei Xu. The network helps show where Shumei Xu may publish in the future.

Co-authorship network of co-authors of Shumei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shumei Xu. A scholar is included among the top collaborators of Shumei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shumei Xu. Shumei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Xiaoyu, Rui Xia, Jianguo Ma, et al.. (2025). Quadruple therapy with immunotherapy and chemotherapy as first-line conversion treatment for unresectable advanced gastric adenocarcinoma: A case report. World Journal of Gastrointestinal Oncology. 17(4). 102258–102258.
2.
Li, Xinxiao, Shumei Xu, Yingying Yang, et al.. (2024). The anthraquinone derivative KA‐4s reduces energy metabolism and enhances the sensitivity of ovarian cancer cells to cisplatin. Molecular Carcinogenesis. 63(11). 2090–2102. 1 indexed citations
3.
4.
Du, Xiaoyu, et al.. (2024). Roles of the tumor microenvironment in the resistance to programmed cell death protein 1 inhibitors in patients with gastric cancer. World Journal of Gastrointestinal Oncology. 16(9). 3820–3831. 1 indexed citations
5.
6.
Jin, Mingwei, Qi An, & Shumei Xu. (2019). Central nervous system disease in childhood acute lymphoblastic leukemia. 71(5). 2 indexed citations
7.
Gao, Yong, Mingwei Jin, Shumei Xu, et al.. (2019). Bioinformatic analysis of Cacybp‐associated proteins using human glioma databases. IUBMB Life. 71(7). 827–834. 6 indexed citations
8.
An, Qi, et al.. (2018). Pediatric mesenchymal stromal cells therapy: an update. Minerva Pediatrics. 70(4). 396–402. 2 indexed citations
9.
Liu, Weiying, et al.. (2018). β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling. Frontiers in Pharmacology. 8. 969–969. 16 indexed citations
10.
Xu, Shumei, et al.. (2018). Genomic-driven discovery of an amidinohydrolase involved in the biosynthesis of mediomycin A. Applied Microbiology and Biotechnology. 102(5). 2225–2234. 19 indexed citations
11.
An, Qi, et al.. (2018). Recent perspectives of pediatric β-thalassaemias. Minerva Pediatrics. 74(3). 365–372. 1 indexed citations
12.
Jin, Mingwei, Shumei Xu, & Qi An. (2017). Pediatric haematopoiesis and related malignancies. Oncology Letters. 14(1). 10–14. 2 indexed citations
13.
Wei, Lili, Yanyan Miao, Shumei Xu, et al.. (2017). Transcriptome analysis of Spodoptera frugiperda 9 (Sf9) cells infected with baculovirus, AcMNPV or AcMNPV-BmK IT. Biotechnology Letters. 39(8). 1129–1139. 19 indexed citations
14.
An, Qi, Yi Wang, Shaoyan Hu, et al.. (2016). Clinical significance of lymphocyte subset changes in hemophagocytic lymphohistiocytosis of children. Experimental and Therapeutic Medicine. 12(6). 3549–3552. 7 indexed citations
15.
Xu, Shumei, et al.. (2016). Protein intake and obesity in young adolescents. Experimental and Therapeutic Medicine. 11(5). 1545–1549. 13 indexed citations
16.
Xu, Shumei, et al.. (2015). Pediatric obesity: Causes, symptoms, prevention and treatment. Experimental and Therapeutic Medicine. 11(1). 15–20. 139 indexed citations
17.
Zheng, Xiaoyao, Xiayan Shao, Chi Zhang, et al.. (2015). Intranasal H102 Peptide-Loaded Liposomes for Brain Delivery to Treat Alzheimer’s Disease. Pharmaceutical Research. 32(12). 3837–3849. 138 indexed citations
18.
Lin, Laixiang, et al.. (2014). Feasibility of β-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on β-Amyloid Hypothesis. PLoS ONE. 9(11). e112052–e112052. 29 indexed citations
19.
Xu, Shumei. (2010). Effects of H102 on IDE and NEP in brains of APP transgenic mice. 1 indexed citations
20.
Xu, Shumei. (2008). The Protective Effect of H102 on Neurotoxicity Induced by Aβ42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Gomes de Macedo Breakdown of academic impact, for papers by Mi‐Jin Jang Breakdown of academic impact, for papers by Peter Ward Breakdown of academic impact, for papers by Amparo Buenestado Breakdown of academic impact, for papers by Robert Wronski Breakdown of academic impact, for papers by Gordon Brandt Breakdown of academic impact, for papers by Janet Rice Breakdown of academic impact, for papers by Ze Li Breakdown of academic impact, for papers by Erika Stefàno Breakdown of academic impact, for papers by Aya Tanabe
Rankless by CCL
2026